NCI Launches Cancer Formulary with Six Pharma Companies

4
218

Make better decisions, avoid FDA tangles, cut costs and boost trial success with Clinical Trials Advisor, the only independent, monthly newsletter focused exclusively on clinical trial operations and good clinical practice compliance.

Every other week, you’ll get the latest clinical study news, as well as practical advice for maximizing your clinical investments. No other resource provides such valuable reporting and training applicable to every area of clinical trials. From ethics to information technology, training to patient recruitment, accreditation to disclosure — if it affects clinical trials, Clinical Trials Advisor covers it.

Subscribe today and get the latest on:

  • Developing regulatory and international news
  • Details and implications of new and draft FDA guidances
  • The steps industry experts recommend taking to improve patient recruitment and site profitability
  • The challenges new clinical trial technologies present
  • Reasons for recent FDA warning letters
  • And much more

Clinical Trials Advisor gives you the early warning on how your studies — and liabilities — are affected by developments not just from Congress and the FDA, but also from policymakers and regulators worldwide.

Plus, Clinical Trials Advisor is backed with a 100 percent money-back guarantee: If at any time you become dissatisfied, you may cancel your subscription and receive a refund of your subscription fee.

Note: For print delivery outside of North America, your credit card will be charged an additional $40 for shipping and handling.

Click here to view the current issue of Clinical Trials Advisor, you must be a subscriber to Clinical Trials Advisor to read full articles.

One-year subscription, monthly, 12 issues

Comments

comments

4 COMMENTS

  1. 我們採用國際及美國食品及藥物管理局FDA認可的CO2 激光儀 LUTRONICS® SPECTRA SPR, 具安全性, 準確度高 . 二氧化碳激光可安全地去除皮膚上的癦痣、肉粒、疣、老人斑等問題。此激光的幼細光束可準確及直接地將要去除的組織氧化,過程快捷,傷口細小及乾淨,對周圍的皮膚傷害減至最少。一般1-2次就可永久去除。

LEAVE A REPLY

Please enter your comment!
Please enter your name here